Published in J Cardiothorac Surg on November 03, 2010
Cardiovascular involvement in autoimmune diseases. Biomed Res Int (2014) 0.82
Rheumatic fever associated with antiphospholipid syndrome: systematic review. J Immunol Res (2014) 0.75
Coronary artery fistula presenting as unstable angina pectoris in patients with antiphospholipid syndrome. Case Rep Med (2013) 0.75
How the dissection laboratory facilitates integration of learning: presence of abdominal aortic aneurysm with a large intracardiac thrombus: a rare cadaver finding. Int J Angiol (2012) 0.75
Impact of Antiphospholipid Syndrome and/or Systemic Lupus Erythematosus on the Long-term Adverse Cardiovascular Outcomes in Patients After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis. Medicine (Baltimore) (2016) 0.75
Antiphospholipid antibodies proposed in the diagnosis of infective endocarditis. Eur J Clin Microbiol Infect Dis (2017) 0.75
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 16.11
The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med (1995) 8.08
Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet (1990) 6.54
The antiphospholipid syndrome. N Engl J Med (2002) 5.42
Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med (2000) 3.70
Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med (1990) 3.35
The antiphospholipid syndrome: ten years on. Lancet (1993) 3.10
Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry. Am J Med (1996) 2.51
Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events. Lancet (1986) 2.38
Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke. Lancet (1992) 2.22
Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol (2000) 2.14
Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) (2001) 2.02
Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) (1998) 2.01
The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg (1995) 1.80
Antiphospholipid antibodies: more than just a disease marker? Immunol Today (1990) 1.79
Antiphospholipid antibodies and the heart. Lessons and pitfalls for the cardiologist. Circulation (1991) 1.68
Lupus anticoagulants. Prog Hemost Thromb (1982) 1.56
Preemptive use of bivalirudin for urgent on-pump coronary artery bypass grafting in patients with potential heparin-induced thrombocytopenia. Ann Thorac Surg (2005) 1.54
Anticardiolipin antibodies and acute myocardial infarction in non-systemic lupus erythmatosus patients: a controlled prospective study. Am J Med (1996) 1.51
Antiphospholipid syndrome: intraoperative and postoperative anticoagulation in cardiac surgery. J Cardiothorac Vasc Anesth (2008) 1.49
High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II. J Biol Chem (2000) 1.46
Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome. Haematologica (1999) 1.43
Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood (2003) 1.37
Coronary artery bypass graft failure--an autoimmune phenomenon? Lancet (1986) 1.34
New anticoagulants. J Thromb Haemost (2005) 1.27
Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2'. J Biol Chem (2003) 1.20
Antiphospholipid syndrome: multiple mechanisms. Clin Exp Immunol (2004) 1.17
Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a "lupus procoagulant" phenomenon. Blood (1998) 1.15
Platelet-endothelial interactions: sepsis, HIT, and antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program (2003) 1.15
Antiprothrombin antibodies detected in two different assay systems. Prevalence and clinical significance in systemic lupus erythematosus. Thromb Haemost (2005) 1.12
Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin. Circ Res (2001) 1.11
Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastins. Br J Haematol (2001) 1.04
Evaluation of cardiac abnormalities and embolic sources in primary antiphospholipid syndrome by transesophageal echocardiography. Lupus (2000) 1.02
Antiphospholipid antibodies and venous thromboembolism. Blood (1995) 1.02
Assessment of hemostatic activation during cardiopulmonary bypass for coronary artery bypass grafting with bivalirudin: results of a pilot study. J Thorac Cardiovasc Surg (2005) 1.01
Anticardiolipin antibodies and recurrent coronary events: a prospective study of 1150 patients. Thrombogenic Factors, and Recurrent Coronary Events Investigators. Circulation (2000) 0.99
Increased morbidity and mortality in patients with antiphospholipid syndrome undergoing valve replacement surgery. J Thorac Cardiovasc Surg (2004) 0.97
Fatal cardiac failure due to myocardial microthrombi in systemic lupus erythematosus. Br Med J (Clin Res Ed) (1988) 0.97
Successful use of bivalirudin for cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia. J Cardiothorac Vasc Anesth (2003) 0.96
Inflammatory response and the endothelium. Thromb Res (2004) 0.94
Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery. Ann Thorac Surg (2004) 0.94
Cardiopulmonary bypass with bivalirudin in type II heparin-induced thrombocytopenia. Ann Thorac Surg (2004) 0.92
The use of direct thrombin inhibitors in cardiovascular surgery in patients with heparin-induced thrombocytopenia. Semin Thromb Hemost (2004) 0.92
Non-criteria manifestations of antiphospholipid syndrome. Lupus (2010) 0.91
Findings at necropsy in the heart of a patient with anticardiolipin syndrome. Br Heart J (1989) 0.90
The antiphospholipid syndrome and heart valve surgery. Eur J Cardiothorac Surg (2007) 0.89
A peptide that mimics the Vth region of beta-2-glycoprotein I reverses antiphospholipid-mediated thrombosis in mice. Lupus (2006) 0.88
Cardiovascular surgical outcomes in patients with the antiphospholipid syndrome--a case-series. Heart Lung Circ (2007) 0.87
Anticardiolipin antibodies in ischaemic heart disease: marker or myth? Br Heart J (1993) 0.86
Tissue factor pathway and the antiphospholipid syndrome. J Autoimmun (2000) 0.86
Operation for chronic pulmonary thromboembolism accompanied by thrombophilia in 8 patients. Ann Thorac Surg (1998) 0.86
Management of anticoagulation during cardiopulmonary bypass in a patient with a circulating lupus anticoagulant. J Cardiothorac Vasc Anesth (1997) 0.85
Successful thrombolytic therapy for acute myocardial infarction in a patient with the antiphospholipid antibody syndrome. Am Heart J (1991) 0.85
Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting. Am J Cardiol (2004) 0.85
Current status of antifibrinolytics in cardiopulmonary bypass and elective deep hypothermic circulatory arrest. Anesthesiol Clin North America (2003) 0.85
Answers to the antiphospholipid-antibody syndrome? N Engl J Med (1995) 0.84
Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndrome. QJM (2000) 0.83
Recognition and management of patients with antiphospholipid antibody syndrome undergoing cardiac surgery. J Cardiothorac Vasc Anesth (1997) 0.82
Coagulation assays for the lupus anticoagulant: review and critique of current methodology. Stroke (1992) 0.82
Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment. Semin Thromb Hemost (2008) 0.82
Association between anticardiolipin antibodies and recurrent cardiac events in patients with acute coronary syndrome. Int Heart J (2005) 0.81
Heart valve surgery in patients with the antiphospholipid syndrome: analysis of a series of nine cases. Eur J Cardiothorac Surg (2009) 0.81
Antiphospholipid antibodies: a new risk factor for restenosis after percutaneous transluminal coronary angioplasty? Autoimmunity (1998) 0.81
The catastrophic antiphospholipid syndrome 1996: acute multi-organ failure associated with antiphospholipid antibodies: a review of 31 patients. Lupus (1996) 0.80
Anticardiolipin antibodies are no marker for survived myocardial infarction. Klin Wochenschr (1990) 0.80
Antiphospholipid syndrome and perioperative hemostatic management of cardiac valvular surgery. Mayo Clin Proc (2000) 0.80
Deep hypothermic circulatory arrest and bivalirudin use in a patient with heparin-induced thrombocytopenia and antiphospholipid syndrome. J Card Surg (2007) 0.80
Standardization of APTT reagents for heparin therapy monitoring: urgent or fading priority? Clin Chem (1997) 0.80
Antiphospholipid antibodies: an elderly statesman Dons new garments. J Rheumatol Suppl (1987) 0.79
Association of anticardiolipin antibodies levels with instent restenosis in patients with coronary artery disease. Indian J Physiol Pharmacol (2009) 0.79
Lipoprotein (a) and anticardiolipin antibodies are risk factors for clinically relevant restenosis after elective balloon percutaneous transluminal coronary angioplasty. Atherosclerosis (2001) 0.79
Acute postoperative biventricular failure associated with antiphospholipid antibody syndrome. Br J Anaesth (2004) 0.79
Use of bivalirudin, a direct thrombin inhibitor, and its reversal with modified ultrafiltration during heart transplantation in a patient with heparin-induced thrombocytopenia. J Heart Lung Transplant (2005) 0.78
Recent advances in antiphospholipid antibody-related valvulopathies. J Autoimmun (2000) 0.78
Bivalirudin, blood loss, and graft patency in coronary artery bypass surgery. Semin Thromb Hemost (2004) 0.78
Assessment of cardiac structure and left atrial appendage functions in primary antiphospholipid syndrome: a transesophageal echocardiographic study. Stroke (2005) 0.78
Species specificity of anti-beta 2 glycoprotein I autoantibodies and its relevance to anticardiolipin antibody quantitation. Thromb Haemost (1996) 0.78
Thrombosis and antiphospholipid syndrome: a preliminary assessment of three antithrombotic treatments. Lupus (1994) 0.78
Antiphospholipid syndrome and cardiac surgery: management of anticoagulation in two patients. Anesth Analg (2000) 0.77
Antiphospholipid antibodies and ischaemic heart disease. J Intern Med (1993) 0.76
Double valve replacement in a patient with anticardiolipin antibody syndrome. Perfusion (1999) 0.76
Anaesthetic implications of the anti-cardiolipin antibody syndrome. Br J Anaesth (1993) 0.76
Radial artery occlusion in primary antiphospholipid syndrome after aortic valve replacement. S Afr Med J (1995) 0.76
Antiphospholipid antibodies lead to increased risk in cardiovascular surgery. Am J Surg (1995) 0.76
Antiphospholipid antibodies in patients with previous myocardial infarction. Lancet (1992) 0.76
Antiphospholipid antibody syndrome in a case with redo coronary artery bypass grafting under cardiopulmonary bypass. Surg Today (1998) 0.76
Acute autoimmune cardiomyopathy in primary antiphospholipid antibody syndrome. Anaesth Intensive Care (2002) 0.76
Antiphospholipid syndrome: insights from animal models. Curr Opin Hematol (2000) 0.76
Aortic valve replacement after previous coronary artery bypass grafting in a patient with antiphospholipid syndrome. Jpn J Thorac Cardiovasc Surg (1998) 0.76
[Thrombosis of a prosthetic mitral valve in the anticardiolipin syndrome]. Dtsch Med Wochenschr (1995) 0.75
Kounis syndrome: a new twist on an old disease. Future Cardiol (2011) 2.51
Right-sided infective endocarditis: surgical management. Eur J Cardiothorac Surg (2012) 2.38
Clinical profile and therapeutic management of patients with atrial fibrillation in Greece: results from the Registry of Atrial Fibrillation to Investigate New Guidelines (RAFTING). Hellenic J Cardiol (2013) 1.98
Low incidence of bronchopleural fistula after pneumonectomy for lung cancer. Interact Cardiovasc Thorac Surg (2009) 1.74
Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress. Med Sci Monit (2003) 1.62
Increased Bax/Bcl-2 ratio up-regulates caspase-3 and increases apoptosis in the thymus of patients with myasthenia gravis. In Vivo (2007) 1.50
Safety of magnetic resonance imaging in patients with implanted cardiac prostheses and metallic cardiovascular electronic devices. Ann Thorac Surg (2011) 1.49
Enoxaparin versus tinzaparin in non-ST-segment elevation acute coronary syndromes: the EVET trial. Am Heart J (2003) 1.43
Modified maximal thymectomy for myasthenia gravis: effect of maximal resection on late neurologic outcome and predictors of disease remission. Ann Thorac Surg (2009) 1.43
Beware of, not only the dogs, but the passionate kissing and the Kounis syndrome. J Cardiovasc Med (Hagerstown) (2011) 1.42
Aortoesophageal fistulas due to thoracic aorta aneurysm: surgical versus endovascular repair. Is there a role for combined aortic management? Med Sci Monit (2008) 1.38
Patient's anxiety and fear of anesthesia: effect of gender, age, education, and previous experience of anesthesia. A survey of 400 patients. J Anesth (2012) 1.18
Strategies to prevent intraoperative lung injury during cardiopulmonary bypass. J Cardiothorac Surg (2010) 1.18
Native valve right sided infective endocarditis. Eur J Intern Med (2013) 1.15
Eosinophilic responses to stent implantation and the risk of Kounis hypersensitivity associated coronary syndrome. Int J Cardiol (2011) 1.09
Frequency of inappropriate and nonrecommended prasugrel prescription: great variations. J Am Coll Cardiol (2014) 1.08
Radial artery as graft for myocardial revascularization. Ann Thorac Surg (2013) 1.08
Multiple cerebral mycotic aneurysms due to left atrial myxoma: are there any pitfalls for the cardiac surgeon? Hellenic J Cardiol (2011) 1.07
Current role of surgery in small cell lung carcinoma. J Cardiothorac Surg (2009) 1.06
Intramural haematoma of the thoracic aorta: who's to be alerted the cardiologist or the cardiac surgeon? J Cardiothorac Surg (2009) 1.02
Pharmacologic prophylaxis for atrial fibrillation following cardiac surgery: a systematic review. J Cardiothorac Surg (2010) 1.01
Heart echinococcus cyst as an incidental finding: early detection might be life-saving. J Cardiothorac Surg (2010) 1.00
Components of the metabolic syndrome and risk for first-ever acute ischemic nonembolic stroke in elderly subjects. Stroke (2005) 0.99
Patient-prosthesis mismatch and strategies to prevent it during aortic valve replacement. Hellenic J Cardiol (2011) 0.98
Helicobacter pylori neutrophil activating protein as target for new drugs against H. pylori inflammation. World J Gastroenterol (2011) 0.97
Deep hypothermia and circulatory arrest in the surgical management of renal tumors with cavoatrial extension. J Card Surg (2009) 0.97
Hypomagnesemia and concurrent acid-base and electrolyte abnormalities in patients with congestive heart failure. Eur J Heart Fail (2002) 0.97
A prospective randomized trial comparing the safety and efficacy of three commercially available closure devices (Angioseal, Vasoseal and Duett). Cardiovasc Intervent Radiol (2002) 0.96
Are there independent predisposing factors for postoperative infections following open heart surgery? J Cardiothorac Surg (2011) 0.96
Risk factors for first-ever acute ischemic non-embolic stroke in elderly individuals. Int J Cardiol (2005) 0.95
Influence of blood transfusions and preoperative anemia on long-term survival in patients operated for non-small cell lung cancer. Lung Cancer (2008) 0.95
Acute type-B aortic dissection: the treatment strategy. Hellenic J Cardiol (2010) 0.95
Massive haemothorax due to subclavian artery rupture: emergency thoracotomy or primary stent-grafting? Heart Lung Circ (2009) 0.93
The need for intra aortic balloon pump support following open heart surgery: risk analysis and outcome. J Cardiothorac Surg (2010) 0.92
Primary aortoesophageal fistula due to thoracic aortic aneurysm: successful surgical treatment. Tex Heart Inst J (2009) 0.91
Congenital hypopituitarism: monitoring after coronary artery bypass grafting. Ann Card Anaesth (2010) 0.91
Treating to target patients with primary hyperlipidaemia: comparison of the effects of ATOrvastatin and ROSuvastatin (the ATOROS study). Curr Med Res Opin (2006) 0.89
Evaluation of urine tumor-associated trypsin inhibitor, CYFRA 21-1, and urinary bladder cancer antigen for detection of high-grade bladder carcinoma. Urology (2008) 0.89
Solitary fibrous tumor of the lung. Gen Thorac Cardiovasc Surg (2008) 0.89
Critical role of residues defining the ligand binding pocket in hepatocyte nuclear factor-4alpha. J Biol Chem (2004) 0.89
Simultaneous off-pump coronary artery bypass graft and nephrectomy. J Card Surg (2008) 0.89
Association between serum gamma-glutamyltransferase and acute ischemic nonembolic stroke in elderly subjects. Arch Med Res (2009) 0.89
Acute left main coronary artery thrombosis due to cocaine use. J Cardiothorac Surg (2010) 0.87
Beneficial effect of the oxygen free radical scavenger amifostine (WR-2721) on spinal cord ischemia/reperfusion injury in rabbits. J Cardiothorac Surg (2009) 0.87
Outcome of patients with acute myocardial infarction admitted in hospitals with or without catheterization laboratory: results from the HELIOS registry. Eur J Cardiovasc Prev Rehabil (2009) 0.87
Routine suction of intercostal drains is not necessary after lobectomy: a prospective randomized trial. World J Surg (2008) 0.86
Cardiac tumors: a retrospective multicenter institutional study. J BUON (2015) 0.86
Sex differentiation with regard to coronary artery disease. J Cardiol (2013) 0.86
Baseline cerebral oximetry values in cardiac and vascular surgery patients: a prospective observational study. J Cardiothorac Surg (2010) 0.85
Acute heart failure caused by a giant hepatocellular metastatic tumor of the right atrium. J Cardiothorac Surg (2011) 0.84
Chemerin and CMKLR1 expression in human arteries and periadventitial fat: a possible role for local chemerin in atherosclerosis? BMC Cardiovasc Disord (2014) 0.83
Aspirin resistance in cardiovascular disease: pathogenesis, diagnosis and clinical impact. Curr Pharm Des (2009) 0.83
The implication of vasa vasorum in surgical diseases of the aorta. Eur J Cardiothorac Surg (2011) 0.83
eComment: Cardiac papillary fibroelastoma: a current assessment. Interact Cardiovasc Thorac Surg (2009) 0.83
Quality of life after coronary artery bypass graft surgery in the elderly. Eur J Cardiovasc Nurs (2008) 0.82
Smoking cessation is associated with reduced long-term mortality and the need for repeat interventions after coronary artery bypass grafting. Eur J Cardiovasc Prev Rehabil (2007) 0.82
Left ventricular diastolic dysfunction of the cardiac surgery patient; a point of view for the cardiac surgeon and cardio-anesthesiologist. J Cardiothorac Surg (2009) 0.82
Surgical decision making in tracheobronchial injuries on the basis of clinical evidences and the injury's anatomical setting: a retrospective analysis. Injury (2010) 0.82
Effect of synthetic peptides corresponding to residues 313-332 of the alphaIIb subunit on platelet activation and fibrinogen binding to alphaIIbbeta3. Eur J Biochem (2004) 0.82
Huge interatrial septal aneurysm: a coincidental but rather fatal finding. Case Rep Med (2011) 0.82
Factors associated with depression and anxiety of hospitalized patients with heart failure. Hellenic J Cardiol (2015) 0.82
Surgical strategies and devices for surgical exclusion of the left atrial appendage: a word of caution. J Card Surg (2013) 0.81
Epidemiological characteristics, management and early outcome of acute myocardial infarction in Greece: the HELlenic Infarction Observation Study. Hellenic J Cardiol (2008) 0.81
In situ cooling in a lung hilar clamping model of ischemia-reperfusion injury. Exp Biol Med (Maywood) (2006) 0.81
Perioperative infusion of low- dose of vasopressin for prevention and management of vasodilatory vasoplegic syndrome in patients undergoing coronary artery bypass grafting-A double-blind randomized study. J Cardiothorac Surg (2010) 0.81
Combined heart surgery and lung tumor resection. Med Sci Monit (2008) 0.81
Transternal repair of a giant Morgagni hernia causing cardiac tamponade in a patient with coexisting severe aortic valve stenosis. J Cardiothorac Surg (2011) 0.81
Coronary artery aneurysms after drug-eluting stent implantation. Interact Cardiovasc Thorac Surg (2011) 0.81
On the structural and functional importance of the highly conserved Glu56 of Thermus thermophilus L4 ribosomal protein. J Mol Biol (2003) 0.81
Imaging of acute aortic syndrome: advantages, disadvantages and pitfalls. Hellenic J Cardiol (2015) 0.80
Associations between body mass index and risks in elderly patients with a first-ever acute ischemic stroke. Arch Intern Med (2003) 0.80
Single or double drain after lung resections? Eur J Cardiothorac Surg (2009) 0.80
Inhibition of platelet activation by peptide analogs of the beta(3)-intracellular domain of platelet integrin alpha(IIb)beta(3) conjugated to the cell-penetrating peptide Tat(48-60). Platelets (2009) 0.80
Is early assessment of cardiac troponin I a valuable predictor of mortality after cardiac surgery? Interact Cardiovasc Thorac Surg (2010) 0.80
Intensive care unit-related generalized neuromuscular weakness due to critical illness polyneuropathy/myopathy in critically ill patients. J Anesth (2014) 0.80
Axillary artery cannulation for cardiopulmonary bypass during surgery on the ascending aorta and arch. J Card Surg (2009) 0.79
Reduced PAF-acetylhydrolase activity associated with Lp(a) in patients with coronary artery disease. Atherosclerosis (2004) 0.79
Structural and biomechanical alterations in rabbit thoracic aortas are associated with the progression of atherosclerosis. Lipids Health Dis (2011) 0.79
Spectroscopy of protonated peptides assisted by infrared multiple photon excitation. J Phys Chem A (2009) 0.79
Medical management of stable angina. Hellenic J Cardiol (2014) 0.79
Simultaneously performed off-pump coronary artery bypass grafting and colectomy: a case report. World J Surg Oncol (2010) 0.79
The role of myocardial ischaemic preconditioning during beating heart surgery: biological aspect and clinical outcome. Interact Cardiovasc Thorac Surg (2011) 0.78
Transauricular balloon angioplasty in rabbit thoracic aorta: a novel model of experimental restenosis. Lipids Health Dis (2014) 0.78